DEATH OPTIONAL.
“The podcast. Long-form conversations about the compounds pharma won't touch.”
“The podcast. Long-form conversations about the compounds pharma won't touch.”
The podcast. Long-form conversations about the compounds pharma won't touch, the researchers who do, and what actually works when you stop waiting for permission.
Dr. M. Scott Mortensen unpacks the regulatory gap between what FDA approves and what actually moves medicine forward. Why peptides, stem cells, and regenerative therapies live outside the approved market — and why the answer isn't shutting it down.
New episodes weekly. Full RSS feed, no paywall. Support the show by donating to Mortensen Medical instead of buying branded supplements you don't need.
Regulatory gap, IRB strategy, and why shutting down compounding pharmacies will cost more lives than it saves.
Mechanism, dosing, injection vs oral, sport rehab data, adverse event profile, and why orthopedists are quietly sending patients to peptide clinics.
The founding thesis. Regenerative medicine, longevity, healthspan vs lifespan, and the difference between dying old and being killed by your treatment.
What the show is, what it isn't, and what's coming.
We're especially interested in clinicians working in regenerative medicine, FDA-counsel lawyers, compounding pharmacists, and patients with well-documented outcomes — positive or adverse. No supplement-pushers. No influencers. No one who sells a protocol.
PITCH → podcast@killer.health →The podcast is editorial. Guests speak for themselves. Nothing said on DEATH OPTIONAL is medical advice. Protocols, compounds, and dosing discussed are for information and research context only. Always work with a licensed physician inside an established clinical relationship before starting, stopping, or modifying any protocol.
No sponsors, no supplement ads, no affiliate codes. Your donation to Mortensen Medical (501(c)(3)) keeps every episode independent and tax-deductible for you.